• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补充医学的经济分析:一项系统综述。

Economic analysis of complementary medicine: a systematic review.

作者信息

White A R, Ernst E

机构信息

Department of Complementary Medicine, School of Postgraduate Medicine and Health Sciences, University of Exeter, Exeter, UK.

出版信息

Complement Ther Med. 2000 Jun;8(2):111-8. doi: 10.1054/ctim.2000.0356.

DOI:10.1054/ctim.2000.0356
PMID:10859604
Abstract

OBJECTIVE

To review systematically all reports of economic analysis of complementary and alternative medicine.

METHOD

Searches were performed in Medline, Embase and AMED for reports of cost description, cost comparison, cost effectiveness, or cost benefit studies. Prospective studies that investigated comparative groups were considered to be of higher quality.

RESULTS

A total of 34 reports was included. Retrospective studies in which a range of therapies are provided in primary care suggest that these may reduce referral and treatment costs, but prospective studies suggest that complementary medicine is an additional expense and does not substitute for orthodox care. For individual therapies, one thorough but retrospective study suggests that carefully targeted acupuncture may reduce referral costs for musculoskeletal problems. One large pragmatic study of spinal manipulative therapy suggests that this treatment may reduce the societal costs of back pain, but four controlled trials found that manipulative therapy does not reduce the costs incurred by the back pain patients themselves or by their health insurance provider.

CONCLUSION

Spinal manipulative therapy for back pain may offer cost savings to society, but it does not save money for the purchaser. There is a paucity of rigorous studies that could provide conclusive evidence of differences in costs and outcomes between other complementary therapies and orthodox medicine. The evidence from methodologically flawed studies is contradicted by more rigorous studies, and there is a need for high quality investigations of the costs and benefits of complementary medicine.

摘要

目的

系统回顾所有补充和替代医学的经济分析报告。

方法

在Medline、Embase和AMED中检索成本描述、成本比较、成本效益或成本效益研究报告。调查比较组的前瞻性研究被认为质量更高。

结果

共纳入34份报告。初级保健中提供一系列疗法的回顾性研究表明,这些疗法可能会降低转诊和治疗成本,但前瞻性研究表明,补充医学是一项额外费用,不能替代传统治疗。对于个别疗法,一项全面但为回顾性的研究表明,针对性强的针灸可能会降低肌肉骨骼问题的转诊成本。一项关于脊柱推拿疗法的大型实用性研究表明,这种治疗可能会降低背痛的社会成本,但四项对照试验发现,推拿疗法并不能降低背痛患者自身或其医疗保险机构产生的成本。

结论

脊柱推拿疗法治疗背痛可能为社会节省成本,但对购买者而言并不省钱。缺乏严格的研究能够提供确凿证据,证明其他补充疗法与传统医学在成本和疗效上存在差异。方法存在缺陷的研究证据与更严格的研究结果相矛盾,因此需要对补充医学的成本和效益进行高质量调查。

相似文献

1
Economic analysis of complementary medicine: a systematic review.补充医学的经济分析:一项系统综述。
Complement Ther Med. 2000 Jun;8(2):111-8. doi: 10.1054/ctim.2000.0356.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Negative pressure wound therapy for surgical wounds healing by primary closure.负压伤口疗法在一期缝合手术伤口愈合中的应用。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD009261. doi: 10.1002/14651858.CD009261.pub7.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.多奈哌齐、卡巴拉汀、加兰他敏和美金刚用于治疗阿尔茨海默病的临床疗效及成本效益
Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. doi: 10.3310/hta10010.
9
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
10
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.

引用本文的文献

1
Systematic Review and Quality Evaluation of Pharmacoeconomic Studies on Traditional Chinese Medicines.系统评价和中医药药物经济学研究的质量评估。
Front Public Health. 2021 Aug 3;9:706366. doi: 10.3389/fpubh.2021.706366. eCollection 2021.
2
Comparative analysis of resource utilization in integrative anthroposophic and all German pediatric inpatient departments.整体人智学与全德儿科住院部的资源利用比较分析。
BMC Health Serv Res. 2020 Oct 12;20(1):939. doi: 10.1186/s12913-020-05782-6.
3
Yoga vs. physical therapy vs. education for chronic low back pain in predominantly minority populations: study protocol for a randomized controlled trial.
瑜伽与物理疗法和教育治疗少数民族人群慢性下腰痛的比较:一项随机对照试验的研究方案。
Trials. 2014 Feb 26;15:67. doi: 10.1186/1745-6215-15-67.
4
Survey based investigation into general practitioner referral patterns for spinal manipulative therapy.基于调查的全科医生对脊柱推拿治疗转诊模式的研究。
Chiropr Man Therap. 2013 May 29;21:16. doi: 10.1186/2045-709X-21-16. eCollection 2013.
5
Management of anxiety and sleep disorders: role of complementary and alternative medicine and challenges of integration with conventional orthodox care.焦虑和睡眠障碍的管理:补充和替代医学的作用,以及与传统主流医疗相结合的挑战。
Chin J Integr Med. 2013 Jan;19(1):5-14. doi: 10.1007/s11655-013-1197-5. Epub 2012 Dec 29.
6
People, plants and health: a conceptual framework for assessing changes in medicinal plant consumption.人与植物和健康:评估药用植物消费变化的概念框架。
J Ethnobiol Ethnomed. 2012 Nov 13;8:43. doi: 10.1186/1746-4269-8-43.
7
CAM practitioners in the Australian health workforce: an underutilized resource.澳大利亚卫生工作者中的补充医学从业者:未充分利用的资源。
BMC Complement Altern Med. 2012 Nov 2;12:205. doi: 10.1186/1472-6882-12-205.
8
Alternative medicine: which way forward?替代医学:路在何方?
J Family Community Med. 2000 May;7(2):13-5.
9
Assessment of potential health risk for arsenic and heavy metals in some herbal flowers and their infusions consumed in China.评估中国部分草药花卉及其浸液中砷和重金属的潜在健康风险。
Environ Monit Assess. 2013 May;185(5):3909-16. doi: 10.1007/s10661-012-2839-y. Epub 2012 Sep 15.
10
Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations.补充疗法和综合护理具有成本效益吗?经济评估的系统评价。
BMJ Open. 2012 Sep 3;2(5). doi: 10.1136/bmjopen-2012-001046. Print 2012.